Results 181 to 190 of about 1,180,459 (201)

Augmenting and Assaying Nav1.1 Protein Quantity for Dravet Syndrome Therapy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Dravet Syndrome (DS) is a developmental and epileptic encephalopathy predominantly caused by heterozygous loss‐of‐function variants in SCN1A, which encodes Nav1.1. Conserved upstream open reading frames (uORFs) in SCN1A were validated to regulate translation in reporter assays, demonstrating the therapeutic viability of increasing Nav1.1 from ...
Aiswarya Saravanan   +7 more
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Mechanisms of substrate processing during ER-associated protein degradation

Nature Reviews Molecular Cell Biology, 2023
Thomas Sommer   +2 more
exaly  

Mechanisms of polymer degradation and erosion

Biomaterials, 1996
Achim Göpferich
exaly  

Development of forced degradation and stability indicating studies of drugs—A review

Journal of Pharmaceutical Analysis, 2014
Prajesh Prajapati   +2 more
exaly  

Home - About - Disclaimer - Privacy